Relating Intra-Tumor Heterogeneity to Morphology and Its Implications for Assessing Response to Therapy. - Matthew Kelly 002; Olivier Noterdaeme; Michael Brady 001 (ISBI, 2007)

The Benefits of an Ontological Patient Model in Clinical Decision-Support. - Mark Austin; Matthew Kelly 002; Michael Brady 001 (AAAI, 2008)

Deep Quantitative Liver Segmentation and Vessel Exclusion to Assist in Liver Assessment. - Benjamin Irving; Chloe Hutton; Andrea Dennis; Sid Vikal; Marija Mavar; Matt Kelly 001; J. Michael Brady (MIUA, 2017)

Novel Quantitative Magnetic Resonance Imaging Features with Liver Function Tests to Distinguish Parenchymal and Biliary Disease. - Katherine Arndtz; Benjamin Irving; Peter Eddowes; Dan Green; Matt Kelly 001; Naomi Jayaratne; Rajarshi Banerjee; Michael Brady 001; Gideon M. Hirschfield (MIUA, 2018)

Regional Assessment of Liver Disease Progression and Response to Therapy by Multi-time Point m-SLIC Correspondence. - Benjamin Irving; Chloe Hutton; Katherine Arndtz; Naomi Jayaratne; Matt Kelly 001; Rajarshi Banerjee; Gideon M. Hirschfield; J. Michael Brady (MIUA, 2018)

Automated Detection of Cystic Lesions in Quantitative T1 Liver Images. - Marta Wojciechowska; Benjamin Irving; Andrea Dennis; Henry R. Wilman; Rajarshi Banerjee; Michael Brady 001; Matt Kelly 001 (MIUA, 2018)

Comparison of Classical Machine Learning & Deep Learning to Characterise Fibrosis & Inflammation Using Quantitative MRI. - Emily Chan; Matt Kelly 001; Julia A. Schnabel (ISBI, 2021)